WELL Health to Report Fourth Quarter and Year End 2024 Financial Results on April 14, 2025 | WHTCF Stock News

Author's Avatar
Apr 09, 2025
Article's Main Image
  • WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) will release its Q4 and Year End 2024 financial results on April 14, 2025, after market close.
  • The company will hold a conference call to discuss the results on April 15, 2025, at 1:00 PM ET.
  • The call will be led by CEO Hamed Shahbazi and CFO Eva Fong, with multiple dial-in options available for participants.

WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF), a digital healthcare company focused on leveraging technology to improve health outcomes, is set to release its Fiscal Fourth Quarter and Year End 2024 financial results on April 14, 2025. The announcement will occur after the market closes, offering insights into the company's performance for the period ending December 31, 2024.

The following day, April 15, 2025, WELL Health will host a conference call and webcast to discuss the results. The call is scheduled for 1:00 PM ET (10:00 AM PT) and will be chaired by Hamed Shahbazi, Chairman and CEO, along with Eva Fong, CFO. Investors and interested parties are encouraged to participate in this event by dialing in 10 minutes prior to the starting time.

Conference call participants can access the call using the following numbers: local dial-in Toronto (437-900-0527), local dial-in Vancouver (604-259-0841), North American toll-free (1-888-510-2154), and international dial-in (1-437-900-0527). Additionally, a live webcast of the conference call will be available for those who prefer to follow along online.

WELL Health's mission is to tech-enable healthcare providers by developing state-of-the-art technologies and services that empower them to improve patient outcomes. The company's comprehensive platform supports over 41,000 healthcare providers across the US and Canada and operates the largest healthcare ecosystem in Canada with over 200 clinics.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.